Healthcare & Life Sciences
Mendus
Swedenmendus.com/
Mendus is a Healthcare & Life Sciences startup based in Sweden, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Mendus
Based in Sweden, Mendus is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Mendus is a clinical-stage biotechnology company developing immunotherapies to reduce tumor recurrence by harnessing the immune system to target residual cancer cells; its lead product vididencel is in clinical development. The company is headquartered in Stockholm, Sweden and is listed on Nasdaq Stockholm (ticker IMMU).
Explore Mendus's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.